eSense-Lab
(ASX:ESE)
Latest Article
$2.6M Capped eSense-Lab Signs US$600k Revenue Deal
Jun 19, 2020
Backed by a new leadership team, ASX-listed biotech junior, eSense-Lab (ASX:ESE) is implementing a new business model that sees it enter joint venture (JV) agreements to quickly reach multiple revenue-generating markets.
Related Articles
Game Changer? ASX Stock Reverse Engineering Cannabis Plants
Jul 2, 2019
Who is the ASX company with transforming qualities that could completely disrupt the cannabis and CBD markets?
